Citation 73472

BARRERO,AF: HAIDOUR,A: DORADO,MM: GRAVALOS,DG: QUESADA,TG:. (1994). LIGNANS FROM THE WOOD OF ABIES PINSAPO.. 57(6)

Citation Details

TitleLIGNANS FROM THE WOOD OF ABIES PINSAPO.
AuthorsBARRERO,AF: HAIDOUR,A: DORADO,MM: GRAVALOS,DG: QUESADA,TG:
Year1994
Volume57
Issue6

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Abies pinsapo (PINACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
None
2
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
WEAK ACTIVITY
3
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
WEAK ACTIVITY
4
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
ACTIVE
5
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
WEAK ACTIVITY
6
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
WEAK ACTIVITY
7
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
WEAK ACTIVITY
8
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
WEAK ACTIVITY
9
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
WEAK ACTIVITY
10
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
INACTIVE
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
EQUIVOCAL
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
EQUIVOCAL
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
EQUIVOCAL
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
EQUIVOCAL
15
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
INACTIVE
16
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LIGNAN,9-9': 4-4'-9-TRIHYDROXY-3-3'-DIMETHOXY:
INACTIVE
17Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
LARICIRESINOL
None
18Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
LARICIRESINOL,9-PARA-COUMAROYL:
None
19
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOL
WEAK ACTIVITY
20
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOL
WEAK ACTIVITY
21
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOL
ACTIVE
22
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
WEAK ACTIVITY
23
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
WEAK ACTIVITY
24
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
WEAK ACTIVITY
25
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
WEAK ACTIVITY
26
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
WEAK ACTIVITY
27
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
INACTIVE
28
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
EQUIVOCAL
29
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
EQUIVOCAL
30
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
EQUIVOCAL
31
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
EQUIVOCAL
32
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
INACTIVE
33
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOLLARICIRESINOL,9-PARA-COUMAROYL:
INACTIVE
34Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
TODOLACTOL A,(7'-S):
None
35Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LARICIRESINOL,9'(R)-HYDROXY:
None
36
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TODOLACTOL A,(7'-S):
EQUIVOCAL
37
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TODOLACTOL A,(7'-S):
ACTIVE
38
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TODOLACTOL A,(7'-S):
ACTIVE
39
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
TODOLACTOL A,(7'-S):
ACTIVE
40
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
TODOLACTOL A,(7'-S):
INACTIVE
41
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
TODOLACTOL A,(7'-S):
INACTIVE
42
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,9'(R)-HYDROXY:
ACTIVE
43
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,9'(R)-HYDROXY:
EQUIVOCAL
44
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,9'(R)-HYDROXY:
ACTIVE
45
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,9'(R)-HYDROXY:
EQUIVOCAL
46
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOL,9'(R)-HYDROXY:
INACTIVE
47
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOL,9'(R)-HYDROXY:
INACTIVE
48Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
LARICIRESINOL,7'(S)-HYDROXY:
None
49Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LARICIRESINOL,7'(R)-HYDROXY:
None
50
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,7'(S)-HYDROXY:LARICIRESINOL,7'(R)-HYDROXY:
EQUIVOCAL
51
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,7'(S)-HYDROXY:LARICIRESINOL,7'(R)-HYDROXY:
EQUIVOCAL
52
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,7'(S)-HYDROXY:LARICIRESINOL,7'(R)-HYDROXY:
EQUIVOCAL
53
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,7'(S)-HYDROXY:LARICIRESINOL,7'(R)-HYDROXY:
EQUIVOCAL
54
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOL,7'(S)-HYDROXY:LARICIRESINOL,7'(R)-HYDROXY:
INACTIVE
55
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOL,7'(S)-HYDROXY:LARICIRESINOL,7'(R)-HYDROXY:
INACTIVE
56Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SESQUIPINSAPOL C
None
57Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
LARICIRESINOL,ISO:
None
58
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,ISO:SESQUIPINSAPOL C
ACTIVE
59
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,ISO:SESQUIPINSAPOL C
EQUIVOCAL
60
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,ISO:SESQUIPINSAPOL C
EQUIVOCAL
61
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LARICIRESINOL,ISO:SESQUIPINSAPOL C
EQUIVOCAL
62
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOL,ISO:SESQUIPINSAPOL C
INACTIVE
63
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LARICIRESINOL,ISO:SESQUIPINSAPOL C
INACTIVE
Show SPARQL Queries (1)